David Epstein
Founder chez BLACK DIAMOND THERAPEUTICS, INC.
Fortune : 5 M $ au 31/03/2024
Profil
David M.
Epstein was the founder of Archemix Corp.
(founded in 2001) where he held the title of Vice President-Biology from 2001 to 2003.
He is also the founder of Black Diamond Therapeutics, Inc. (founded in 2014) where he currently holds the title of Director.
In addition to his founding positions, Dr. Epstein has held former job positions.
He was a Director at MetaStat, Inc. from 2013 to 2015 and served as the Chief Scientific Officer-Oncology & Senior VP at OSI Pharmaceuticals, Inc. from 2006 to 2013.
Dr. Epstein's education history includes a doctorate degree from Brandeis University and an undergraduate degree from Lewis & Clark College (Oregon).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/06/2023 | 936 569 ( 1,81% ) | 5 M $ | 31/03/2024 |
Postes actifs de David Epstein
| Sociétés | Poste | Début |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Founder | 01/01/2014 |
Anciens postes connus de David Epstein
| Sociétés | Poste | Fin |
|---|---|---|
| METASTAT, INC. | Director/Board Member | 01/04/2015 |
| OSI PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2013 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Founder | 01/01/2003 |
| Duke-NUS Graduate Medical School Singapore | Corporate Officer/Principal | - |
Formation de David Epstein
| Brandeis University | Doctorate Degree |
| Lewis & Clark College (Oregon) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
